{"gene":"GNG2","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":2024,"finding":"The deubiquitylase Otub1 interacts with GNG2 (the γ-subunit of the heterotrimeric G protein) and modulates its ubiquitylation status, thereby controlling GNG2 protein stability. Loss of Otub1 increases GNG2 ubiquitylation and alters splenic B cell chemotactic responsiveness to Cxcl12, Cxcl13, and S1P, with downstream effects on Ca2+ mobilization, F-actin polymerization, and B cell positioning in the spleen.","method":"Co-immunoprecipitation of Otub1 with Gng2, ubiquitylation assays, proximal mapping (BioID-type), Otub1-KO murine B cells with functional readouts (Ca2+ flux, F-actin polymerization, chemotaxis assays, in vivo splenic localization)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, ubiquitylation assay, multiple orthogonal functional readouts in KO cells, in vivo validation in single rigorous study","pmids":["38270191"],"is_preprint":false},{"year":2022,"finding":"GNG2 directly interacts with MRAS at the cell membrane, as demonstrated by FRET, and this interaction suppresses ERK and AKT activity in breast cancer cells, promoting apoptosis and inhibiting proliferation.","method":"FRET assay for direct GNG2-MRAS interaction, co-localization by immunofluorescence at cell membrane, GNG2 overexpression with phospho-ERK and phospho-AKT readouts, in vitro proliferation and apoptosis assays, in vivo xenograft model","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRET establishes direct interaction, multiple functional assays, single lab","pmids":["35322009"],"is_preprint":false},{"year":2012,"finding":"Overexpression of GNG2 alone in human malignant melanoma cells suppresses proliferation with decreased c-SRC and AKT activities and increased p21(Cip/WAF1) expression; conversely, GNG2 depletion enhances proliferation with increased c-SRC and AKT activities and decreased p21(Cip/WAF1).","method":"GNG2 overexpression and siRNA knockdown in SK-Mel28 and A375P melanoma cells; western blot for c-SRC, AKT, p21; proliferation assays in vitro; nude mouse xenograft in vivo","journal":"Journal of dermatological science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional gain/loss-of-function, multiple signaling readouts, single lab","pmids":["23031273"],"is_preprint":false},{"year":2014,"finding":"GNG2 overexpression in human malignant melanoma cells inhibits migration and invasion (up to 10-fold) with decreased focal adhesion kinase (FAK) activity; GNG2 knockdown in A375P cells enhances migration and invasion with increased FAK activity.","method":"GNG2 overexpression in SK-Mel28 cells and siRNA knockdown in A375P cells; migration/invasion assays (wound healing, Boyden chamber); western blot for phospho-FAK","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional gain/loss-of-function, FAK activity as molecular readout, single lab","pmids":["24660107"],"is_preprint":false},{"year":2025,"finding":"GNG2 overexpression in colorectal cancer cells induces G0/G1 cell cycle arrest and inhibits the PI3K/AKT/mTOR signaling axis, suppressing proliferation, migration, invasion, and brain metastasis in vitro and in an orthotopic xenograft mouse model.","method":"GNG2 overexpression in CRC cell lines; cell cycle analysis; western blot for PI3K/AKT/mTOR pathway components; in vitro migration/invasion assays; orthotopic xenograft model with brain metastasis readout; immunohistochemistry and multiplex immunofluorescence","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (in vitro + in vivo), signaling pathway readouts, single lab","pmids":["39805936"],"is_preprint":false},{"year":2021,"finding":"Knockdown of KCNJ2 in papillary thyroid carcinoma cells upregulates GNG2 expression, and this upregulation mediates the inhibition of proliferation, migration, invasion, and EMT caused by KCNJ2 interference.","method":"KCNJ2 siRNA knockdown with and without concurrent GNG2 siRNA knockdown in thyroid carcinoma cell lines; colony formation, MTT, wound healing, Transwell, and western blot for EMT markers","journal":"Molecular medicine reports","confidence":"Low","confidence_rationale":"Tier 3 / Weak — epistasis by double knockdown but single lab, limited mechanistic depth on how KCNJ2 regulates GNG2","pmids":["34212982"],"is_preprint":false}],"current_model":"GNG2 (G-protein γ2 subunit) functions as a component of heterotrimeric G-protein signaling whose protein stability is regulated by the deubiquitylase Otub1, which removes K48-linked polyubiquitin chains to prevent proteasomal degradation; in B cells, GNG2 couples to chemokine receptors (CXCR4/CXCR5/S1P receptors) to drive Ca2+ mobilization, F-actin polymerization, and directed migration. In cancer contexts, GNG2 acts as a tumor suppressor by directly interacting with MRAS at the cell membrane to suppress ERK and AKT/mTOR activity, and by decreasing FAK activity to limit invasion, collectively inducing G0/G1 arrest and apoptosis."},"narrative":{"mechanistic_narrative":"GNG2 is the γ2 subunit of heterotrimeric G proteins that couples chemokine and lipid receptor signaling to cytoskeletal and migratory output, and acts as a growth-suppressive node in multiple cancers [PMID:38270191, PMID:35322009]. In B cells, GNG2 transduces signals from chemoattractant receptors responding to Cxcl12, Cxcl13, and S1P, driving Ca2+ mobilization, F-actin polymerization, and directed positioning in the spleen; its protein abundance is set by the deubiquitylase Otub1, which removes ubiquitin to stabilize GNG2, so that Otub1 loss increases GNG2 ubiquitylation and reshapes chemotactic responsiveness [PMID:38270191]. In tumor cells, GNG2 functions as a suppressor of proliferation and invasion: it directly binds MRAS at the cell membrane to dampen ERK and AKT activity [PMID:35322009], and its overexpression lowers c-SRC, AKT, and FAK activity while elevating p21, restraining migration, invasion, and PI3K/AKT/mTOR signaling and imposing G0/G1 arrest and apoptosis across melanoma, breast, and colorectal cancer models [PMID:23031273, PMID:24660107, PMID:39805936].","teleology":[{"year":2012,"claim":"Established that GNG2 is not merely a passive G-protein subunit but a regulator of tumor cell proliferation, linking it to c-SRC/AKT signaling and the cell-cycle inhibitor p21.","evidence":"bidirectional GNG2 overexpression and siRNA knockdown in melanoma cells with signaling western blots and xenografts","pmids":["23031273"],"confidence":"Medium","gaps":["How GNG2 mechanistically lowers c-SRC/AKT activity not resolved","Direct molecular partner mediating the effect not identified"]},{"year":2014,"claim":"Extended GNG2's suppressive role from proliferation to invasion by tying it to focal adhesion kinase activity.","evidence":"GNG2 gain/loss-of-function in melanoma cells with migration/invasion assays and phospho-FAK readout","pmids":["24660107"],"confidence":"Medium","gaps":["Whether GNG2 acts directly on FAK or upstream unclear","Single tumor type tested"]},{"year":2021,"claim":"Placed GNG2 downstream of an ion channel regulator, showing it is required for the anti-tumor phenotype of KCNJ2 loss in thyroid carcinoma.","evidence":"double siRNA epistasis of KCNJ2 and GNG2 in thyroid carcinoma lines with EMT marker readouts","pmids":["34212982"],"confidence":"Low","gaps":["Mechanism by which KCNJ2 regulates GNG2 expression unknown","Single lab, no in vivo confirmation"]},{"year":2022,"claim":"Identified a direct molecular partner explaining GNG2's growth suppression — membrane MRAS binding linked to ERK/AKT downregulation.","evidence":"FRET demonstration of direct GNG2-MRAS interaction with phospho-ERK/AKT, apoptosis, proliferation, and xenograft assays in breast cancer","pmids":["35322009"],"confidence":"Medium","gaps":["Structural basis of GNG2-MRAS binding not defined","Whether this interaction operates outside breast cancer untested"]},{"year":2024,"claim":"Defined how GNG2 protein levels are controlled, identifying Otub1-mediated deubiquitylation as a stability switch governing GNG2-dependent B cell chemotaxis.","evidence":"reciprocal Co-IP, ubiquitylation assays, BioID proximal mapping, and Otub1-KO murine B cells with Ca2+, F-actin, chemotaxis, and in vivo splenic readouts","pmids":["38270191"],"confidence":"High","gaps":["E3 ligase that ubiquitylates GNG2 not identified","Whether Otub1 regulates GNG2 in non-immune/cancer contexts unknown"]},{"year":2025,"claim":"Consolidated the tumor-suppressor model by showing GNG2 enforces G0/G1 arrest and blocks metastasis via PI3K/AKT/mTOR inhibition.","evidence":"GNG2 overexpression in colorectal cancer cells with cell-cycle analysis, pathway western blots, and orthotopic xenograft with brain metastasis readout","pmids":["39805936"],"confidence":"Medium","gaps":["Direct receptor or partner driving PI3K/AKT/mTOR suppression in CRC not pinpointed","Single lab"]},{"year":null,"claim":"It remains unresolved how GNG2's canonical role as a Gβγ chemotaxis effector mechanistically connects to its tumor-suppressive MRAS/AKT/FAK functions, and which receptors and E3 ligases integrate these activities.","evidence":"","pmids":[],"confidence":"Low","gaps":["Unified mechanism linking G-protein signaling and growth suppression absent","E3 ligase for GNG2 ubiquitylation unidentified","Structural detail of GNG2 partner interactions lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0]}],"complexes":["heterotrimeric G protein"],"partners":["OTUB1","MRAS"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P59768","full_name":"Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2","aliases":["G gamma-I"],"length_aa":71,"mass_kda":7.8,"function":"Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems (PubMed:29925951, PubMed:33762731, PubMed:34239069, PubMed:35610220, PubMed:35714614, PubMed:35835867, PubMed:36087581, PubMed:36989299, PubMed:37327704, PubMed:37935376, PubMed:37935377, PubMed:37963465, PubMed:38168118, PubMed:38552625). The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction (PubMed:29925951, PubMed:33762731, PubMed:34239069, PubMed:35610220, PubMed:35714614, PubMed:35835867, PubMed:36087581, PubMed:36989299, PubMed:37327704, PubMed:37935376, PubMed:37935377, PubMed:37963465, PubMed:38168118, PubMed:38552625)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P59768/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNG2","classification":"Not Classified","n_dependent_lines":11,"n_total_lines":1208,"dependency_fraction":0.009105960264900662},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"GNB1","stoichiometry":0.2},{"gene":"STK25","stoichiometry":0.2},{"gene":"STK26","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/GNG2","total_profiled":1310},"omim":[{"mim_id":"618689","title":"NETRIN G2; NTNG2","url":"https://www.omim.org/entry/618689"},{"mim_id":"616984","title":"NEUROPEPTIDE VF PRECURSOR; NPVF","url":"https://www.omim.org/entry/616984"},{"mim_id":"612836","title":"PHOSPHOLIPASE C, ETA-2; PLCH2","url":"https://www.omim.org/entry/612836"},{"mim_id":"612139","title":"PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 2; PREX2","url":"https://www.omim.org/entry/612139"},{"mim_id":"611893","title":"PLECKSTRIN HOMOLOGY DOMAIN- AND RhoGEF DOMAIN-CONTAINING PROTEIN G2; PLEKHG2","url":"https://www.omim.org/entry/611893"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":80.6},{"tissue":"testis","ntpm":107.0}],"url":"https://www.proteinatlas.org/search/GNG2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P59768","domains":[{"cath_id":"4.10.260.10","chopping":"1-51","consensus_level":"medium","plddt":93.7775,"start":1,"end":51}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P59768","model_url":"https://alphafold.ebi.ac.uk/files/AF-P59768-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P59768-F1-predicted_aligned_error_v6.png","plddt_mean":89.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNG2","jax_strain_url":"https://www.jax.org/strain/search?query=GNG2"},"sequence":{"accession":"P59768","fasta_url":"https://rest.uniprot.org/uniprotkb/P59768.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P59768/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P59768"}},"corpus_meta":[{"pmid":"22957104","id":"PMC_22957104","title":"Topography of Gng2- and NetrinG2-expression suggests an insular origin of the human claustrum.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22957104","citation_count":38,"is_preprint":false},{"pmid":"35322009","id":"PMC_35322009","title":"GNG2 acts as a tumor suppressor in breast cancer through stimulating MRAS signaling.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35322009","citation_count":24,"is_preprint":false},{"pmid":"24660107","id":"PMC_24660107","title":"GNG2 inhibits invasion of human malignant melanoma cells with decreased FAK activity.","date":"2014","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24660107","citation_count":21,"is_preprint":false},{"pmid":"23031273","id":"PMC_23031273","title":"Functional analysis of GNG2 in human malignant melanoma cells.","date":"2012","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/23031273","citation_count":16,"is_preprint":false},{"pmid":"30928649","id":"PMC_30928649","title":"3'UTR variants of TNS3, PHLDB1, NTN4, and GNG2 genes are associated with IgA nephropathy risk in Chinese Han population.","date":"2019","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30928649","citation_count":16,"is_preprint":false},{"pmid":"34212982","id":"PMC_34212982","title":"Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/34212982","citation_count":13,"is_preprint":false},{"pmid":"31790618","id":"PMC_31790618","title":"Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients.","date":"2019","source":"The International journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31790618","citation_count":10,"is_preprint":false},{"pmid":"31730405","id":"PMC_31730405","title":"miR-30a-GNG2 and miR-15b-ACSS2 Interaction Pairs May Be Potentially Crucial for Development of Abdominal Aortic Aneurysm by Influencing Inflammation.","date":"2019","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31730405","citation_count":10,"is_preprint":false},{"pmid":"39805936","id":"PMC_39805936","title":"GNG2 inhibits brain metastases from colorectal cancer via PI3K/AKT/mTOR signaling pathway.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39805936","citation_count":9,"is_preprint":false},{"pmid":"33655887","id":"PMC_33655887","title":"miRNAs regulating the expressions of NTF3, GNG2 and ITGA7 are involved in the pathogenesis of abdominal aortic aneurysm in mice.","date":"2021","source":"General physiology and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/33655887","citation_count":1,"is_preprint":false},{"pmid":"38270191","id":"PMC_38270191","title":"The Deubiquitylase Otub1 Regulates the Chemotactic Response of Splenic B Cells by Modulating the Stability of the γ-Subunit Gng2.","date":"2024","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/38270191","citation_count":0,"is_preprint":false},{"pmid":"41836115","id":"PMC_41836115","title":"Astragaloside IV Ameliorates Diabetic Cardiomyopathy by Suppressing the GNG2/MRAS-ERK Signaling Pathway.","date":"2026","source":"International journal of general medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41836115","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8601,"output_tokens":1725,"usd":0.025839,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8516,"output_tokens":2269,"usd":0.049653,"stage2_stop_reason":"end_turn"},"total_usd":0.075492,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2024,\n      \"finding\": \"The deubiquitylase Otub1 interacts with GNG2 (the γ-subunit of the heterotrimeric G protein) and modulates its ubiquitylation status, thereby controlling GNG2 protein stability. Loss of Otub1 increases GNG2 ubiquitylation and alters splenic B cell chemotactic responsiveness to Cxcl12, Cxcl13, and S1P, with downstream effects on Ca2+ mobilization, F-actin polymerization, and B cell positioning in the spleen.\",\n      \"method\": \"Co-immunoprecipitation of Otub1 with Gng2, ubiquitylation assays, proximal mapping (BioID-type), Otub1-KO murine B cells with functional readouts (Ca2+ flux, F-actin polymerization, chemotaxis assays, in vivo splenic localization)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, ubiquitylation assay, multiple orthogonal functional readouts in KO cells, in vivo validation in single rigorous study\",\n      \"pmids\": [\"38270191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GNG2 directly interacts with MRAS at the cell membrane, as demonstrated by FRET, and this interaction suppresses ERK and AKT activity in breast cancer cells, promoting apoptosis and inhibiting proliferation.\",\n      \"method\": \"FRET assay for direct GNG2-MRAS interaction, co-localization by immunofluorescence at cell membrane, GNG2 overexpression with phospho-ERK and phospho-AKT readouts, in vitro proliferation and apoptosis assays, in vivo xenograft model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRET establishes direct interaction, multiple functional assays, single lab\",\n      \"pmids\": [\"35322009\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Overexpression of GNG2 alone in human malignant melanoma cells suppresses proliferation with decreased c-SRC and AKT activities and increased p21(Cip/WAF1) expression; conversely, GNG2 depletion enhances proliferation with increased c-SRC and AKT activities and decreased p21(Cip/WAF1).\",\n      \"method\": \"GNG2 overexpression and siRNA knockdown in SK-Mel28 and A375P melanoma cells; western blot for c-SRC, AKT, p21; proliferation assays in vitro; nude mouse xenograft in vivo\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional gain/loss-of-function, multiple signaling readouts, single lab\",\n      \"pmids\": [\"23031273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GNG2 overexpression in human malignant melanoma cells inhibits migration and invasion (up to 10-fold) with decreased focal adhesion kinase (FAK) activity; GNG2 knockdown in A375P cells enhances migration and invasion with increased FAK activity.\",\n      \"method\": \"GNG2 overexpression in SK-Mel28 cells and siRNA knockdown in A375P cells; migration/invasion assays (wound healing, Boyden chamber); western blot for phospho-FAK\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional gain/loss-of-function, FAK activity as molecular readout, single lab\",\n      \"pmids\": [\"24660107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GNG2 overexpression in colorectal cancer cells induces G0/G1 cell cycle arrest and inhibits the PI3K/AKT/mTOR signaling axis, suppressing proliferation, migration, invasion, and brain metastasis in vitro and in an orthotopic xenograft mouse model.\",\n      \"method\": \"GNG2 overexpression in CRC cell lines; cell cycle analysis; western blot for PI3K/AKT/mTOR pathway components; in vitro migration/invasion assays; orthotopic xenograft model with brain metastasis readout; immunohistochemistry and multiplex immunofluorescence\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (in vitro + in vivo), signaling pathway readouts, single lab\",\n      \"pmids\": [\"39805936\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Knockdown of KCNJ2 in papillary thyroid carcinoma cells upregulates GNG2 expression, and this upregulation mediates the inhibition of proliferation, migration, invasion, and EMT caused by KCNJ2 interference.\",\n      \"method\": \"KCNJ2 siRNA knockdown with and without concurrent GNG2 siRNA knockdown in thyroid carcinoma cell lines; colony formation, MTT, wound healing, Transwell, and western blot for EMT markers\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — epistasis by double knockdown but single lab, limited mechanistic depth on how KCNJ2 regulates GNG2\",\n      \"pmids\": [\"34212982\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNG2 (G-protein γ2 subunit) functions as a component of heterotrimeric G-protein signaling whose protein stability is regulated by the deubiquitylase Otub1, which removes K48-linked polyubiquitin chains to prevent proteasomal degradation; in B cells, GNG2 couples to chemokine receptors (CXCR4/CXCR5/S1P receptors) to drive Ca2+ mobilization, F-actin polymerization, and directed migration. In cancer contexts, GNG2 acts as a tumor suppressor by directly interacting with MRAS at the cell membrane to suppress ERK and AKT/mTOR activity, and by decreasing FAK activity to limit invasion, collectively inducing G0/G1 arrest and apoptosis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GNG2 is the γ2 subunit of heterotrimeric G proteins that couples chemokine and lipid receptor signaling to cytoskeletal and migratory output, and acts as a growth-suppressive node in multiple cancers [#0, #1]. In B cells, GNG2 transduces signals from chemoattractant receptors responding to Cxcl12, Cxcl13, and S1P, driving Ca2+ mobilization, F-actin polymerization, and directed positioning in the spleen; its protein abundance is set by the deubiquitylase Otub1, which removes ubiquitin to stabilize GNG2, so that Otub1 loss increases GNG2 ubiquitylation and reshapes chemotactic responsiveness [#0]. In tumor cells, GNG2 functions as a suppressor of proliferation and invasion: it directly binds MRAS at the cell membrane to dampen ERK and AKT activity [#1], and its overexpression lowers c-SRC, AKT, and FAK activity while elevating p21, restraining migration, invasion, and PI3K/AKT/mTOR signaling and imposing G0/G1 arrest and apoptosis across melanoma, breast, and colorectal cancer models [#2, #3, #4].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Established that GNG2 is not merely a passive G-protein subunit but a regulator of tumor cell proliferation, linking it to c-SRC/AKT signaling and the cell-cycle inhibitor p21.\",\n      \"evidence\": \"bidirectional GNG2 overexpression and siRNA knockdown in melanoma cells with signaling western blots and xenografts\",\n      \"pmids\": [\"23031273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How GNG2 mechanistically lowers c-SRC/AKT activity not resolved\", \"Direct molecular partner mediating the effect not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended GNG2's suppressive role from proliferation to invasion by tying it to focal adhesion kinase activity.\",\n      \"evidence\": \"GNG2 gain/loss-of-function in melanoma cells with migration/invasion assays and phospho-FAK readout\",\n      \"pmids\": [\"24660107\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GNG2 acts directly on FAK or upstream unclear\", \"Single tumor type tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed GNG2 downstream of an ion channel regulator, showing it is required for the anti-tumor phenotype of KCNJ2 loss in thyroid carcinoma.\",\n      \"evidence\": \"double siRNA epistasis of KCNJ2 and GNG2 in thyroid carcinoma lines with EMT marker readouts\",\n      \"pmids\": [\"34212982\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mechanism by which KCNJ2 regulates GNG2 expression unknown\", \"Single lab, no in vivo confirmation\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified a direct molecular partner explaining GNG2's growth suppression — membrane MRAS binding linked to ERK/AKT downregulation.\",\n      \"evidence\": \"FRET demonstration of direct GNG2-MRAS interaction with phospho-ERK/AKT, apoptosis, proliferation, and xenograft assays in breast cancer\",\n      \"pmids\": [\"35322009\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of GNG2-MRAS binding not defined\", \"Whether this interaction operates outside breast cancer untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined how GNG2 protein levels are controlled, identifying Otub1-mediated deubiquitylation as a stability switch governing GNG2-dependent B cell chemotaxis.\",\n      \"evidence\": \"reciprocal Co-IP, ubiquitylation assays, BioID proximal mapping, and Otub1-KO murine B cells with Ca2+, F-actin, chemotaxis, and in vivo splenic readouts\",\n      \"pmids\": [\"38270191\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase that ubiquitylates GNG2 not identified\", \"Whether Otub1 regulates GNG2 in non-immune/cancer contexts unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Consolidated the tumor-suppressor model by showing GNG2 enforces G0/G1 arrest and blocks metastasis via PI3K/AKT/mTOR inhibition.\",\n      \"evidence\": \"GNG2 overexpression in colorectal cancer cells with cell-cycle analysis, pathway western blots, and orthotopic xenograft with brain metastasis readout\",\n      \"pmids\": [\"39805936\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct receptor or partner driving PI3K/AKT/mTOR suppression in CRC not pinpointed\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how GNG2's canonical role as a Gβγ chemotaxis effector mechanistically connects to its tumor-suppressive MRAS/AKT/FAK functions, and which receptors and E3 ligases integrate these activities.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Unified mechanism linking G-protein signaling and growth suppression absent\", \"E3 ligase for GNG2 ubiquitylation unidentified\", \"Structural detail of GNG2 partner interactions lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [\"heterotrimeric G protein\"],\n    \"partners\": [\"OTUB1\", \"MRAS\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":3,"faith_total":3,"faith_pct":100.0}}